Metformin May Help or Harm Aging Based on Your Insulin Sensitivity
New study reveals metformin's anti-aging effects depend entirely on whether you're insulin resistant or sensitive.
20 articles
New study reveals metformin's anti-aging effects depend entirely on whether you're insulin resistant or sensitive.
Wake Forest study explores whether the diabetes drug metformin can trigger cellular changes linked to longevity in healthy people.
Major trial tests whether diabetes drug metformin can prevent frailty syndrome that affects millions of aging adults.
Clinical trial tested whether metformin could improve surgical outcomes and reduce hospital stays in non-diabetic older patients.
Columbia University tested whether the diabetes drug metformin could slow memory loss in people with mild cognitive impairment.
Small trial tested whether the diabetes drug metformin could enhance immune response to pneumonia vaccine in aging adults.
Clinical trial tested whether metformin could enhance resistance training benefits for muscle mass and strength in older adults.
Four-year study examined whether metformin could protect blood vessels in people with metabolic syndrome beyond its diabetes benefits.
Small trial tests whether diabetes drug metformin can enhance immune response to flu vaccination in aging adults.
VA study tests whether combining lifestyle changes with metformin can reverse muscle loss and frailty in obese older adults.
Multi-omic analysis reveals GLP-1 receptor agonists counter aging processes across multiple organ systems and biological pathways.
Diabetes drugs like empagliflozin show surprising anti-aging effects โ mimicking caloric restriction and reducing senescent cell burden.
University of Pennsylvania researchers investigated how insulin resistance and testosterone interact in women after menopause.
Mediterranean diet, resistance training, and diabetes medication combined to combat sarcopenia and improve metabolic health in older adults.
A new framework redefines age-related insulin resistance as a systemic collapse of metabolic resilience spanning muscle, fat, brain, and more.
New England Journal review explores the expanding therapeutic potential of GLP-1 drugs beyond diabetes treatment.
176-person trial tested whether pioglitazone could improve liver health by targeting insulin resistance in patients with fatty liver disease.
A mouse study reveals how aging and poor diet synergistically disrupt liver thyroid hormone metabolism, accelerating fatty liver disease โ and why resmetirom may help.
A 6-month AI-driven personalized diet intervention cut BMI by 33% and reduced biological age by 8 years in morbidly obese patients.
Combined mitochondrial therapy restored muscle function and reduced fatigue in mouse model of Gulf War Illness.